ArticleMedicine and science in sports and exercise2026
Creating and Evaluating a Prediction Equation for VO 2peak in Individuals with Early Stage, Never Medicated Parkinson's Disease.
Article in Medicine and science in sports and exercise, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundParkinson's disease (PD) is a neurodegenerative nervous system condition causing motor and nonmotor symptoms. Endurance training is commonly prescribed in people with PD for possible slowing of disease progression. Since people with PD exhibit lower cardiorespiratory fitness, it is important to understand peak aerobic capacity (VO 2peak ) in people with PD. VO 2peak prediction equations may be used when cardiopulmonary exercise testing (CPET) is unavailable; however, exercise-based PD-specific prediction equations are lacking. The purpose of the study was to develop a PD-specific VO 2peak prediction equation and to compare this equation to published VO 2peak prediction equations.
methodsThis study included N = 127 never-medicated individuals with PD, aged 40-80 yr, Hoehn and Yahr stages 1-2, within 5 yr of diagnosis, and exercising ≤3 d/wk, who completed a treadmill CPET. Linear regression analyses were performed to generate the VO 2peak equation from a validation subsample, which was applied to a cross-validation subsample. The equation was compared with two published equations for healthy adults.
resultsThe PD-specific VO 2peak equation was: VO 2peak (mL/kg/min) = 12.466 + 0.149 × (treadmill speed [m/min]) + 85.7 × (treadmill grade [%, as a decimal]) - 2.383 × (sex [0 = male, 1 = female]) - 0.135 × (age [years]). There was no difference between estimated and measured VO 2peak in the cross-validation subsample. Our equation successfully predicted VO 2peak in early PD, whereas VO 2peak was over- and underestimated in people with PD by the American College of Sports Medicine and Foster equations, respectively.
conclusionsClinicians can estimate VO 2peak in individuals with PD to identify those for whom endurance exercise training should be a major health priority, develop an exercise prescription, and assess changes in VO 2peak over time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.